Therapy Market Research Reports & Industry Analysis

... number of immigrants of Asian, Middle Eastern and African origin. Additionally, it is likely that many people who... Euromonitor International's Food Intolerance in Sweden report tracks the developments of health-associated product types and the healthy-option positioning of competing brands across different ...

The Competitive Intelligence report Smallpox Vaccines & Therapeutics as of August 2013 provides a competitor analysis in the development pipelines of novel vaccines and therapeutics for prophylaxis of Variola virus infection and treatment of smallpox. Purchase of the pdf report includes a 6-month online ...

... products to avoid gluten and sugar (in the sense of purchasing products for diabetic people) or lactose deliberately. Euromonitor International's Food Intolerance in Czech Republic report tracks the developments of health-associated product types and the healthy-option positioning of competing brands across ...

... in 141 people of the US population. The disease is marked by an inability to process foods containing gluten, causing abdominal pain, discomfort, fatigue and diarrhoea. ... data. Why buy this report? Get a detailed picture of the Food Intolerance market; Pinpoint growth sectors and identify factors driving ...

... in 2009-2012, this report presents a picture of the real development of China market and changes in the overall market size. Hot Areas ... growth rate and profitability of this industry in China. Product definition Pollution treatment medical materials products mentioned in this report is a general concept ...

... , ARS6 million and ARS91 million respectively. Euromonitor International's Food Intolerance in Argentina report tracks the developments of health-associated product types and the healthy-option positioning of competing brands across different food sectors. It provides the latest retail sales data 2008-2012, ...

... and those suffering from lactose intolerance. The second group is... Euromonitor International's Food Intolerance in Mexico report tracks the developments of health- ... types and the healthy-option positioning of competing brands across different food sectors. It provides the latest retail sales data 2008-2012, ...

... on distribution of and difference in performance in regions of Mainland China in terms of the pollution treatment medical materials mfg. industry; To figure out the hot ... for pollution treatment medical materials mfg. industry, find out the potential provinces and cities suitable for investment as well as the ...

... Drugs and related technologies to transform the market Biomarkers and diagnostic imaging technologies, including structural, functional, and molecular imaging Deep ... there, helping you stay ahead. Eight ways Alzheimer's Disease Therapeutics and Diagnostics: World Market 2013-2023 helps you In particular ...

... to boost the growth. According to RNCOS’ new research report, “Global Gene Therapy Market Analysis”, major focus has been made on the ongoing ... therapy include cardiac conditions, genetic disorders and neurological diseases. An effective analysis of the key therapeutic areas has been included in the report. ...

... undisclosed settlement dates, based on available facts. In other words, Para IV Plus is not merely a database but is a tool with in-depth insights for every ... gives list of potential API buyers To a pharma company desirous of banking on the Para IV litigations, this tool will help them strategize their entry ...

Pricing: Japan Database: $15,000/- subscription p/a Formulating a competitive landscape of various therapeutic classes in Japan is challenging viz a viz the US and EU markets ... reliable Source in public domain 5. Large contribution of ‘Japan Only’ products - difficult to make competitive landscapes for overseas ...

Endocyte’s (ECYT) SMDC technology platform and drug pipeline caught investor’s ... our initiation report released on 19th April, 2013 on ECYT titled “Small and Powerful Targeted Therapy!

... titled ‘Global Irritable Bowel Syndrome Market: Trends and Opportunities (2012-17)’ provides an in depth analysis of IBS market on a global level. The report presents the global market sizing of IBS and ... Sucampo Executive Summary Irritable Bowel Syndrome or IBS is a gastrointestinal disorder in which the colon muscle contracts more readily. The high prevalence of this syndrome could be estimated ...

... one of the highest impact rendering drivers of the multiple sclerosis therapeutics market. Many organizations over the globe are actively involved in ... high prescription rates & price North America dominated the overall multiple sclerosis therapeutics market with revenue estimates at over 13.0 billion in 2015. ...

... be prevented. “UAE IVF Treatment Market Analysis” research report gives detailed information on following aspects related to booming IVF treatment market in UAE: Current Market Scenario IVF Treatment Market Potential Treatment cycle & Birth Rate Fertility Treatment Loan ...

... FirstWord research is provided in two comprehensive modules: The KOL Insight: HIV module provides a complete review underpinned by exclusive in-depth interviews with ... Protease inhibitors CCR5 inhibitor Expert Opinion for Real World Insights The data and analysis in the report is enriched through the ...

... GLP-1 secretion in glucose depended manner is the key trait of this class. Through this, GPR agonist controls hyperglycemia without hypoglycemia, and ...

Hemophilia is an inherited (X-linked recessive trait), lifelong bleeding disorder that prevents blood from clotting due to insufficient or lack of adequate amount of clotting factors – Factor VIII (FVIII) and Factor IX (proteins in blood that control bleeding). Plasma-derived FVIII and FIX proteins were used ...

... is the most up-to-date market report focusing on Cellular Therapy and the HSCT/Cord Blood Market Landscape, published by Select Biosciences. In this ... . Select Biosciences has also provided a detailed quantitative analysis of the cord blood field as it is rapidly evolving. Our coverage provides hard numbers ...

... Our work explains, exploring many issues. What affects the application of epigenetics? Our report discusses issues and events affecting that science, ... and commercial possibilities. Nine ways Epigenetic Therapies and Technologies: World Market Prospects 2013-2023 helps you To sum up, our investigation ...

... Intelligence Report Enzyme Replacement & Enhancement Therapies (ERT) as of January 2013 provides a competitor analysis in the development pipeline of novel enzyme replacement therapies and of enzyme enhancement therapies to treat human genetic diseases/lysosomal storage diseases and exocrine pancreatic ...

... Drivers & Limiters Mergers & Acquisitions Customer Feedback and Market Monitoring SubSegments Included: Fetal and neonatal monitoring Invasive and Non-Invasive ... and evaluates the current state of the market including existing and potential markets, product average selling prices, and unit volumes. The ...

This report is an in-depth financial evaluation of the Denmark Dental Practices. Using the unique Plimsoll method of analysis, each of the largest 100 companies is individually assessed and ranked against each other and compared to industry averages.Using the most ...

... examines the Causes of ADHD including Genetics Environmental and Social causes. Attention Deficit Hyperactivity Disorder ADHD is one of the more common mental ... settings including home school and in relationships with peers. If untreated the disorder can have long-term adverse effects into adolescence and ...

Charting the Future Multiple Sclerosis Market LandscapeOver the next five years, the global multiple sclerosis (MS) market is set to grow from $12.3 billion in 2011 to $17.3 billion in 2016. Primary d...

... of QVA-149 from fifth and final successful pivotal clinical study result (SPARK) from IGNITE program on August 30th, 2012. The fixed dose LABA ... in the US and 2012-2013 in the EU and hence any market share loss would be immaterial from Pfizer perspective. The LABA/LAMA FDC will also ...

Analyse the latest global RA market players and products, and start mapping your future market parameters with Therapy Trends’ Consensus Outlook: Rheumatoid Arthritis, which includes the following com...

What the future holds Over the next few years, the global Rheumatoid Arthritis (RA) market is expected to grow from $16.5 billion in 2011 to $23.4 billion in 2016. This expansion of the market will b...

Therapy Trends KOL Insight: Rheumatoid Arthritis analyses the current and predicted key issues, clinical advances and late-stage pipeline products in the international and US RA markets. KOL Insight g...

Gilead’s supremacy in the HIV space in 2012-18 should remain intact with the successful launch of ... , please read our report released on 3rd May, 2012 on Gilead titled “After HIV -Poised to Deliver the Best Anti-Viral Treatment Options for HCV!”

... , pelvic inflammatory diseases, etc. Today, arrays of treatment options to treat infertility are readily available in India. These include medications for ovulation induction ... IUI, IVF, and ICSI (intra cytoplasmic sperm injection). India has become one of the favored destinations for infertility treatments such as IVF due to several ...

This report analyzes the worldwide markets for Osteoporosis Therapeutics in US$ Million by the following Therapeutic Classes: Bisphosphonates, ERT Drugs, SERMs, Calcitonins, ... 2017. Also, a six-year historic analysis is provided for these markets. The report profiles 49 companies including many key and niche ...

This report analyzes the worldwide markets for Herpes Simplex Virus Treatment in US$ Million. The report provides separate comprehensive analytics for the US, ... , Inc., Novartis International AG, Sanofi, Starpharma Holdings Limited, and Vical. Market data and analytics are derived from primary and secondary ...

Protein-based therapies have found a prominent place in the biopharmaceutical industry since the launch of human insulin product. They have become one of the most effective clinical methods to treat w...

An incisive report and dynamic analyst briefing service delivering insight from the most influential Multiple Sclerosis (MS) Key Opinion Leaders to map the current treatment landscape and analyse futu...

In this updated issue of ‘Japan-Domestic Pharma Market Summary’ for 2012, we present major 10 Thx Class in Japan which covers ~40% of total Japan domestic pharma market (~¥8.0 trillion). This will ... breakthroughs in each class – which includes products from all pharma companies operating in Japan including MNCs.

... with G551D mutation), we see little risk to Vertex (VRTX) profitability for at least next three years ... of IL28B CC Genotype. Vertex has also accelerated the pace of developing IFN-free drugs to remain in the ... 14th Feb., 2012 on Vertex titled “IFN-free Oral HCV Treatment – Vertex Not Out of the Race Yet ...

Gilead (GILD) is poised for further growth, based on the FY12 ... GILD a step closer towards its goal to deliver the “best-in-class IFN-free oral pill” for HCV. Other acquisitions ... read our report released on 10th Feb., 2012 on Gilead Sciences titled “Providing the Best Antiviral Treatment Options for HIV and HCV!”

This report analyzes the Global market for Gene Therapy in US$ Million. Annual estimates and forecasts are provided for the period 2009 through ... GenVec, Oxford BioMedica, Shenzhen SiBiono GeneTech Co., Ltd., Transgene, and Vical Inc. Market data and analytics are derived from primary and secondary research. ...

... anecdotes, market briefs, and concise summaries of research findings. The report offers an aerial view of the global oxygen therapy industry, identifies major short to medium term market challenges, and growth drivers. Regional markets elaborated upon include United States ...

HIV endemic has had devastating economic, social, health and psychological impacts over the years affecting millions of households in a significant manner over the last decade. Despite the concrete ef...

The present Competitive Intelligence report about HIV Small Molecule Therapeutics used to treat human immunodeficiency virus (HIV) infections provides a competitor evaluation in the field of marketed...

... management. This Kalorama Information report, The World Market for Prescription Arthritis Treatments, details the market for these treatments. The report provides ... There are several issues and trends that are shaping this market. Some of the topics, discussed in this report include: US Economic Impact ...

This report analyzes the worldwide markets for Autoimmune Disease Therapeutics in US$ Million by the following Therapeutic Class: Rheumatoid Arthritis (Biologics), Multiple ... 2017. Also, a six-year historic analysis is provided for these markets. The report profiles 112 companies including many key and niche ...

This report analyzes the worldwide markets for Multiple Myeloma Therapeutics in US$ Million. The report provides separate comprehensive analytics for the US, ... , Inc., Millennium Pharmaceuticals, Seattle Genetics, and Ziopharm Oncology, Inc. Market data and analytics are derived from primary and secondary ...

This report analyzes the worldwide markets for Overactive Bladder (OAB) Therapeutics in US$ Million. The report provides separate comprehensive analytics for ... ., SALVAT Biotech, Sepracor Pharmaceuticals, Inc., and Watson Pharmaceuticals, Inc. Market data and analytics are derived from primary and secondary ...

This report analyzes the worldwide markets for Irritable Bowel Syndrome (IBS) Therapeutics in US$ Million. The report provides separate comprehensive analytics for the US, Japan, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2009 through 2017. Also, a six-year ...

Single User PDF Format: US$ 1,800.00 Multi-User License: US$ 2,800.00 Hard Copy: US$ 2,200.00 CD-ROM: US$ 2,200.00 Within the global pharmaceutical industry, protein therapeutics has b...

Medivir’s Xerese fetched $45m for the company from Meda AB for US, ... , please read our report released on 29th June on MVIR titled “Monetizing Cold Sores to Focus On Improved Protease Inhibitors for HCV Treatment” and ...